Clinical trial

Multi-Center Trial of High-resolution Transrectal Ultrasound Versus Standard Low-resolution Transrectal Ultrasound for the Identification of Clinically Significant Prostate Cancer

NCT02079025

Drugs and interventions used in this trial

2 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

Search this trial's interventions

DEVICE · Unmapped registry intervention High-resolution ultrasound guided prostate biopsy Find medicine records · Find other trials using this name

DEVICE · Unmapped registry intervention Standard ultrasound guided prostate biopsy Find medicine records · Find other trials using this name

Study at a glance

Registry-backed

Multi-Center Trial of High-resolution Transrectal Ultrasound Versus Standard Low-resolution Transrectal Ultrasound for the Identification of Clinically Significant Prostate Cancer

Design: INTERVENTIONAL · Status: COMPLETED · Phase: NA

Read study objectives, eligibility and outcome measures at ClinicalTrials.gov

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2013-12-01

PhaseNA

Conditions

Prostatic Neoplasmsunresolved

Prostate Cancerverified · MONDO: prostate cancer

Cancer of the Prostateunresolved

Interventions

High-resolution ultrasound guided prostate biopsyDEVICE

Standard ultrasound guided prostate biopsyDEVICE

Sponsors & collaborators

Exact Imaginglead sponsor

Mapped research locations

BaltimoreMaryland, United States1 TorontoOntario, Canada1 CalgaryAlberta, Canada1 QuébecQuebec, Canada1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT02079025 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.